Publication: Ocular injury due to potassium permanganate granules
Issued Date
2018-01-23
Resource Type
ISSN
16632699
Other identifier(s)
2-s2.0-85041535837
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Case Reports in Ophthalmology. Vol.9, No.1 (2018), 132-137
Suggested Citation
Chareenun Chirapapaisan, Pinnita Prabhasawat, Sabong Srivannaboon, Vatookarn Roongpoovapatr, Piyada Chitsuthipakorn Ocular injury due to potassium permanganate granules. Case Reports in Ophthalmology. Vol.9, No.1 (2018), 132-137. doi:10.1159/000486922 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46996
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Ocular injury due to potassium permanganate granules
Other Contributor(s)
Abstract
© 2018 The Author(s) Published by S. Karger AG, Basel. Purpose: We report a rare case of ocular injury due to potassium permanganate (KMnO4) granules in a child. Methods: This is a retrospective case report. Results: A 2-year-old boy was transferred to our emergency room with severe pain in his right eye, inflamed eyelids, and brownish stains on his fingers. Chemical injury was suspected. Copious eye irrigation was immediately performed. Diffuse brownish splotches were then observed at the inferior bulbar conjunctiva. Otherwise, systemic organs were intact. Complete eye exam under general anesthesia revealed a 5-mm epithelial defect at the central cornea, along with generalized conjunctival injection and limbal ischemia, inferiorly. Multiple semi-dissolved granules of KMnO4 trapped in the inferior fornix were identified. The chemical particles were gradually washed out and removed; however, the brownish stains remained. The patient received preservative-free steroid, antibiotic eye drops, and lubricants as regular management for mild to moderate degree of ocular burn. Pseudomembrane developed early and transformed into symblepharon within a few days after the injury. Membrane adhesion was lysed, and more aggressive medications were then substituted. Commercial amniotic membrane (PROKERA®) was also applied to promote wound healing and to prevent recurrence of symblepharon. The ocular surface was eventually restored, and corneal transparency was preserved. Conclusion: Ocular injury with the granular form of KMnO4 is rare. Its toxicity is comparable to concentrated KMnO4 solution. However, the dissolved particles that had been absorbed in the stained conjunctiva were continuously released and damaged the ocular surface more than we primarily anticipated. Awareness of this condition and prompt management yield a good treatment outcome.